• Elephas Biosciences placed its elive Edge tissue-cutting technology at Mount Sinai to support bladder cancer immunotherapy research.
• Researchers will use the automated instrument to prepare live tumor fragments from core needle biopsies and cored resection samples.
• The research aims to better understand differences in immunotherapy response by studying live tumor tissue outside the body.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elephas Biosciences Corp. published the original content used to generate this news brief on November 10, 2026, and is solely responsible for the information contained therein.